ClinicalTrials.gov
ClinicalTrials.gov Menu

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00142337
Recruitment Status : Completed
First Posted : September 2, 2005
Last Update Posted : January 6, 2012
Sponsor:
Information provided by (Responsible Party):
Marc Lallemant, Institut de Recherche pour le Developpement

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2006
  Actual Study Completion Date : February 2009
Publications of Results:
Other Publications: